NCT01340196View on ClinicalTrials.gov

Drug Drug Interaction of BI 201335 and Tenofovir

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

June 30, 2011

Conditions
HIV Infections
Interventions
DRUG

tenofovir/BI 201335

tenofovir medium dose once daily (qd) for first 15 days; BI 201335 medium dose twice daily (bid) on days 8 through 22 with last dose on morning of day 22

Trial Locations (1)

Unknown

1220.50.0001 Boehringer Ingelheim Investigational Site, Buffalo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01340196 - Drug Drug Interaction of BI 201335 and Tenofovir | Biotech Hunter | Biotech Hunter